TRDA files Form 144 to sell 2,500 shares

TRDA issuer filed a Form 144 to sell 2,500 shares of Common Stock.

Rhea-AI Filing Summary

TRDA issuer filed a Form 144 to sell 2,500 shares of Common Stock. The notice lists the securities as previously exercised stock options with a cash sale method dated 03/15/2024. The filing also reports recent Rule 10b5-1 sales by Kory Wentworth on 03/10/2026 (11,388 shares), 03/09/2026 (5,089 shares), 03/04/2026 (7,988 shares), 03/03/2026 (5,712 shares) and 03/02/2026 (2,939 shares).

Key Figures

Registered shares for sale: 2,500 shares 10b5-1 sale on 03/10/2026: 11,388 shares 10b5-1 sale on 03/09/2026: 5,089 shares +3 more

6 metrics

Registered shares for sale 2,500 shares Form 144; previously exercised stock options dated 03/15/2024

10b5-1 sale on 03/10/2026 11,388 shares Reported Rule 10b5-1 sale by Kory Wentworth; gross proceeds $148,215.96

10b5-1 sale on 03/09/2026 5,089 shares Reported Rule 10b5-1 sale by Kory Wentworth; gross proceeds $66,162.60

10b5-1 sale on 03/04/2026 7,988 shares Reported Rule 10b5-1 sale by Kory Wentworth; gross proceeds $97,892.14

10b5-1 sale on 03/03/2026 5,712 shares Reported Rule 10b5-1 sale by Kory Wentworth; gross proceeds $67,152.56

10b5-1 sale on 03/02/2026 2,939 shares Reported Rule 10b5-1 sale by Kory Wentworth; gross proceeds $34,262.57

Key Terms

Form 144, 10b5-1, Previously Exercised Stock Options

3 terms

Form 144 regulatory

"Filed to sell 2,500 shares of Common Stock"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for KORY WENTWORTH One Design Center Place"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Previously Exercised Stock Options financial

"Common | 03/15/2024 | Previously Exercised Stock Options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does TRDA's Form 144 disclose about the sale?

The Form 144 discloses a proposed sale of 2,500 shares of Common Stock, described as previously exercised stock options dated 03/15/2024. It also lists several Rule 10b5‑1 executions by Kory Wentworth in March 2026.

Who executed recent 10b5-1 sales for TRDA and when?

The filing shows Rule 10b5‑1 sales executed by Kory Wentworth on 03/10/2026, 03/09/2026, 03/04/2026, 03/03/2026, and 03/02/2026. Each line lists the share count and gross proceeds.

How many shares were sold on 03/10/2026 under the 10b5-1 plan?

On 03/10/2026, the filing reports a Rule 10b5‑1 sale of 11,388 shares for gross proceeds of $148,215.96, as disclosed in the Form 144 excerpt.

Are the securities in the Form 144 from option exercises or new issuances?

The Form 144 indicates the 2,500 shares are from previously exercised stock options dated 03/15/2024, and the sale method is listed as Cash in the excerpt.

Does the filing state the sale method for the registered shares?

Yes. The excerpt lists the sale method for the 2,500 shares as Cash, tied to the previously exercised stock options dated 03/15/2024.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/01/2026 - 04:38 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001725663
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ENTRADA THERAPEUTICS INC
SEC File Number	001-40969
Address of Issuer	One Design Center Place, Suite 17-500 Boston MASSACHUSETTS 02210
Phone	8575209158
Name of Person for Whose Account the Securities are To Be Sold	KORY WENTWORTH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2500	31550.00	38284313	04/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2024	Previously Exercised Stock Options	Issuer			2500	03/15/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for KORY WENTWORTH One Design Center Place, Suite 17-500 Boston MA 02210	Common	03/10/2026	11388	148215.96
10b5-1 Sales for KORY WENTWORTH One Design Center Place, Suite 17-500 Boston MA 02210	Common	03/09/2026	5089	66162.60
10b5-1 Sales for KORY WENTWORTH One Design Center Place, Suite 17-500 Boston MA 02210	Common	03/04/2026	7988	97892.14
10b5-1 Sales for KORY WENTWORTH One Design Center Place, Suite 17-500 Boston MA 02210	Common	03/03/2026	5712	67152.56
10b5-1 Sales for KORY WENTWORTH One Design Center Place, Suite 17-500 Boston MA 02210	Common	03/02/2026	2939	34262.57

144: Remarks and Signature

Remarks
Date of Notice	04/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kory Wentworth
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)